Trials / Suspended
SuspendedNCT04205734
Methotrexate Polyglutamate Measurements in Patients With Inflammatory Bowel Disease
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year – 21 Years
- Healthy volunteers
- —
Summary
There are currently no serum levels to help guide appropriate methotrexate therapy. Data from this study will assess the correlation between dosing and whole blood methotrexate(MTX) polyglutamate measurements in children and adolescents with IBD.
Detailed description
This is a cross-sectional study design. Subjects will be requested to provide one blood sample to be collected during the conduct of their routine clinical care. Data related to the diagnosis and interval assessment of enrolled subjects will also be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MTX Assessment | Measurement of Methotrexate Polyglutamate levels. |
Timeline
- Start date
- 2021-01-30
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2019-12-19
- Last updated
- 2023-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04205734. Inclusion in this directory is not an endorsement.